CANCER NANOMEDICINE

Trojan horses for immunotherapy

Article metrics

Responsive polymersomes enhance the action of STING-targeting cyclic dinucleotides in cancer therapy.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Trojan attack.

References

  1. 1.

    Adams, D. et al. N. Engl. J. Med. 379, 11–21 (2018).

  2. 2.

    Coelho, T. et al. N. Engl. J. Med. 369, 819–829 (2013).

  3. 3.

    Shae, D. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-018-0342-5 (2019).

  4. 4.

    Chen, Q., Sun, L. & Chen, Z. J. Nat. Immunol. 17, 1142–1149 (2016).

  5. 5.

    Ablasser, A. et al. Nature 498, 380–384 (2013).

  6. 6.

    Corrales, L., McWhirter, S. M., Dubensky, T. W. & Gajewski, T. F. J. Clin. Invest. 126, 2404–2411 (2016).

  7. 7.

    Woo, S.-R. et al. Immunity 41, 830–842 (2014).

  8. 8.

    Corrales, L. et al. Cell Rep. 11, 1018–1030 (2015).

  9. 9.

    Fu, J. et al. Sci. Transl. Med. 7, 283ra52 (2015).

  10. 10.

    Foote, J. B. et al. Cancer Immunol. Res. 5, 468–479 (2017).

  11. 11.

    Hanson, M. C. et al. J. Clin. Invest. 125, 2532–2546 (2015).

  12. 12.

    Koshy, S. T., Cheung, A. S., Gu, L., Graveline, A. R. & Mooney, D. J. Adv. Biosyst. 1, 1600013 (2017).

  13. 13.

    Manganiello, M. J., Cheng, C., Convertine, A. J., Bryers, J. D. & Stayton, P. S. Biomaterials 33, 2301–2309 (2012).

Download references

Author information

Correspondence to Jeffrey A. Hubbell or Melody A. Swartz.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hubbell, J.A., Swartz, M.A. Trojan horses for immunotherapy. Nat. Nanotechnol. 14, 196–197 (2019) doi:10.1038/s41565-019-0380-7

Download citation